RT info:eu-repo/semantics/article
T1 Peripheral neuropathies derived from COVID-19: New perspectives for treatment
A1 Córdova Martínez, Alfredo
A1 Caballero García, Alberto
A1 Pérez Valdecantos, Daniel
A1 Roche Collado, Enrique
A1 Noriega González, David César
K1 Lipoic acid
K1 α-lipoic acid
K1 Antioxidants
K1 Antioxidantes
K1 COVID-19
K1 Biochemistry
K1 Enzymes
K1 Enzimas
K1 Clinical enzymology
K1 Neurology
K1 Pathology
K1 Nerves, Peripheral - Diseases
K1 Nervios periféricos - Enfermedades
K1 Nervous system - Diseases
K1 Nervioso, Sistema - Enfermedades
K1 Neuropatia
K1 Vitamins
K1 Vitaminas
K1 2302 Bioquímica
K1 2302.09 Enzimología
K1 3205.07 Neurología
K1 3207 Patología
AB Peripheral neuropathies constitute a group of disorders affecting the peripheral nervous system. Neuropathies have multiple causes such as infections (i.e., COVID-19), diabetes, and nutritional (low vitamin levels), among others. Many micronutrients, such as vitamins (A, C, D, E, B6, B12, and folate), certain minerals (Fe, Mg, Zn, Se, and Cu), and ω-3 fatty acids have immunomodulatory effects. Therefore, they may play an instrumental role in the treatment of COVID-19 infection. However, many COVID-19 patients can undergo neuropathy. In this context, there is a wealth of information on a variety of first-, second-, and third-line treatment options. This review focuses on the application of nutraceutical strategies in order to improve the symptomatology of neuropathy and neuropathic pain in patients that suffered from COVID-19. Our aim is to provide an alternative vision to traditional medical-pharmacological treatment through nutraceuticals.
PB MDPI
SN 2227-9059
YR 2022
FD 2022
LK https://uvadoc.uva.es/handle/10324/62672
UL https://uvadoc.uva.es/handle/10324/62672
LA eng
NO Biomedicines, 2022, Vol. 10, Nº. 5, 1051
NO Producción Científica
DS UVaDOC
RD 18-nov-2024